To study the role of Quantitative Sensory Testing in detection of Diabetic Neuropathy.
Not Applicable
- Conditions
- Health Condition 1: null- Diabetes
- Registration Number
- CTRI/2012/07/002834
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 86
Inclusion Criteria
1. Age 18 and above.
2. Diabetic patients who underwent Quantitative Sensory Testing (QST).
Exclusion Criteria
1. Patients with known vitamin B12 deficiency, chronic inflammatory polyneuropathy.
2. Patients taking neurotoxic drugs (cytotoxic drugs, isoniazid, metronidazole, chloramphenicol, nitrofurantoin, amiodarone, phenytoin, simvastatin).
3. Patients who present with heavy alcohol abuse (12), >=75 g daily.
4. Patients with known vasculitis.
5. Patients with known heavy metal poisoning.
6. Patients suffering from cancer or on chemotherapy.
7. Patients with severe chronic kidney disease based on clinical findings.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method